Terahertz otoscope and potential for diagnosing otitis media

Young Bin Ji; In Seok Moon; Hyeon Sang Bark; Sang Hoon Kim; Dong Woo Park; Sam Kyu Noh; Yong Min Huh; Jin Seok Suh; Seung Jae Oh; Tae In Jeon

doi:10.1364/BOE.7.001201

Terahertz otoscope and potential for diagnosing otitis media

Young Bin Ji, In Seok Moon, Hyeon Sang Bark, Sang Hoon Kim, Dong Woo Park, Sam Kyu Noh, Yong Min Huh, Jin Seok Suh, Seung Jae Oh, Tae In Jeon

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

Abstract

We designed and fabricated a novel terahertz (THz) otoscope to help physicians to diagnose otitis media (OM) with both THz diagnostics and conventional optical diagnostics. We verified the potential of this tool for diagnosing OM using mouse skin tissue and a human tympanic membrane samples prior to clinical application.

Original language	English
Pages (from-to)	1201-1209
Number of pages	9
Journal	Biomedical Optics Express
Volume	7
Issue number	4
DOIs	https://doi.org/10.1364/BOE.7.001201
Publication status	Published - 2016 Mar 9

Bibliographical note

Funding Information:
6. Stevens GA, Alkema L, Black RE, et al; The GATHER Working Group. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. Lancet. 2016; 388(10062):e19-e23. doi:10.1016/S0140-6736(16) 30388-9 7. Karimkhani C, Boyers LN, Margolis DJ, et al. Comparing cutaneous research funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases with 2010 global burden of disease results. PLoS One. 2014;9(7):e102122. doi:10.1371/journal.pone.0102122 8. Institue for Health Metrics and Evaluation. Global health data exchange. Accessed May 4, 2020. http://ghdx.healthdata.org/ 9. Murray CJ, Ezzati M, Flaxman AD, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012;380(9859):2063-2066. doi:10.1016/S0140-6736(12)61899-6 10. Hay SI, Abajobir AA, Abate KH, et al; GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet.

Funding Information:
reported receiving personal fees from TARGET-DERM and grants from Pfizer outside the submitted work. Dr Dunnick reported receiving grants from Pfizer, Celgene, and Kyowa outside the submitted work. Dr Singh reported receiving personal fees from Crealta/Horizon, Medisys, Fidia, UBM LLC, Trio Health, Medscape, WebMD, Clinical Care Options, Clearview Healthcare Partners, Putnam Associates, Spherix, Practice Point Communications, the National Institutes of Health, the American College of Rheumatology, Simply Speaking, Amarin Pharmaceuticals, and Viking Pharmaceuticals as well as nonfinancial support from the Food and Drug Administration Arthritis Advisory Committee, Steering Committee of OMERACT (Outcome Measures in Rheumatology), Veterans Affairs Rheumatology Field Advisory Committee, and the University of Alabama at Birmingham Cochrane Musculoskeletal Group Satellite Center on Network Meta-Analysis outside the submitted work. Dr Dellavalle reported receiving grants from Pfizer Pharmaceuticals, stock and meeting expense reimbursement from Altus labs, and personal fees from ParaPRO outside the submitted work. No other disclosures were reported.

Publisher Copyright:
© 2016 Optical Society of America.

All Science Journal Classification (ASJC) codes

Biotechnology
Atomic and Molecular Physics, and Optics

Access to Document

10.1364/BOE.7.001201

Cite this

@article{d29dbce7c2764996a26308cdba3dd97f,

title = "Terahertz otoscope and potential for diagnosing otitis media",

abstract = "We designed and fabricated a novel terahertz (THz) otoscope to help physicians to diagnose otitis media (OM) with both THz diagnostics and conventional optical diagnostics. We verified the potential of this tool for diagnosing OM using mouse skin tissue and a human tympanic membrane samples prior to clinical application.",

author = "Ji, {Young Bin} and Moon, {In Seok} and Bark, {Hyeon Sang} and Kim, {Sang Hoon} and Park, {Dong Woo} and Noh, {Sam Kyu} and Huh, {Yong Min} and Suh, {Jin Seok} and Oh, {Seung Jae} and Jeon, {Tae In}",

note = "Funding Information: 6. Stevens GA, Alkema L, Black RE, et al; The GATHER Working Group. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. Lancet. 2016; 388(10062):e19-e23. doi:10.1016/S0140-6736(16) 30388-9 7. Karimkhani C, Boyers LN, Margolis DJ, et al. Comparing cutaneous research funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases with 2010 global burden of disease results. PLoS One. 2014;9(7):e102122. doi:10.1371/journal.pone.0102122 8. Institue for Health Metrics and Evaluation. Global health data exchange. Accessed May 4, 2020. http://ghdx.healthdata.org/ 9. Murray CJ, Ezzati M, Flaxman AD, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012;380(9859):2063-2066. doi:10.1016/S0140-6736(12)61899-6 10. Hay SI, Abajobir AA, Abate KH, et al; GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. Funding Information: reported receiving personal fees from TARGET-DERM and grants from Pfizer outside the submitted work. Dr Dunnick reported receiving grants from Pfizer, Celgene, and Kyowa outside the submitted work. Dr Singh reported receiving personal fees from Crealta/Horizon, Medisys, Fidia, UBM LLC, Trio Health, Medscape, WebMD, Clinical Care Options, Clearview Healthcare Partners, Putnam Associates, Spherix, Practice Point Communications, the National Institutes of Health, the American College of Rheumatology, Simply Speaking, Amarin Pharmaceuticals, and Viking Pharmaceuticals as well as nonfinancial support from the Food and Drug Administration Arthritis Advisory Committee, Steering Committee of OMERACT (Outcome Measures in Rheumatology), Veterans Affairs Rheumatology Field Advisory Committee, and the University of Alabama at Birmingham Cochrane Musculoskeletal Group Satellite Center on Network Meta-Analysis outside the submitted work. Dr Dellavalle reported receiving grants from Pfizer Pharmaceuticals, stock and meeting expense reimbursement from Altus labs, and personal fees from ParaPRO outside the submitted work. No other disclosures were reported. Publisher Copyright: {\textcopyright} 2016 Optical Society of America.",

year = "2016",

month = mar,

day = "9",

doi = "10.1364/BOE.7.001201",

language = "English",

volume = "7",

pages = "1201--1209",

journal = "Biomedical Optics Express",

issn = "2156-7085",

publisher = "The Optical Society",

number = "4",

}

TY - JOUR

T1 - Terahertz otoscope and potential for diagnosing otitis media

AU - Ji, Young Bin

AU - Moon, In Seok

AU - Bark, Hyeon Sang

AU - Kim, Sang Hoon

AU - Park, Dong Woo

AU - Noh, Sam Kyu

AU - Huh, Yong Min

AU - Suh, Jin Seok

AU - Oh, Seung Jae

AU - Jeon, Tae In

N1 - Funding Information: 6. Stevens GA, Alkema L, Black RE, et al; The GATHER Working Group. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. Lancet. 2016; 388(10062):e19-e23. doi:10.1016/S0140-6736(16) 30388-9 7. Karimkhani C, Boyers LN, Margolis DJ, et al. Comparing cutaneous research funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases with 2010 global burden of disease results. PLoS One. 2014;9(7):e102122. doi:10.1371/journal.pone.0102122 8. Institue for Health Metrics and Evaluation. Global health data exchange. Accessed May 4, 2020. http://ghdx.healthdata.org/ 9. Murray CJ, Ezzati M, Flaxman AD, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012;380(9859):2063-2066. doi:10.1016/S0140-6736(12)61899-6 10. Hay SI, Abajobir AA, Abate KH, et al; GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. Funding Information: reported receiving personal fees from TARGET-DERM and grants from Pfizer outside the submitted work. Dr Dunnick reported receiving grants from Pfizer, Celgene, and Kyowa outside the submitted work. Dr Singh reported receiving personal fees from Crealta/Horizon, Medisys, Fidia, UBM LLC, Trio Health, Medscape, WebMD, Clinical Care Options, Clearview Healthcare Partners, Putnam Associates, Spherix, Practice Point Communications, the National Institutes of Health, the American College of Rheumatology, Simply Speaking, Amarin Pharmaceuticals, and Viking Pharmaceuticals as well as nonfinancial support from the Food and Drug Administration Arthritis Advisory Committee, Steering Committee of OMERACT (Outcome Measures in Rheumatology), Veterans Affairs Rheumatology Field Advisory Committee, and the University of Alabama at Birmingham Cochrane Musculoskeletal Group Satellite Center on Network Meta-Analysis outside the submitted work. Dr Dellavalle reported receiving grants from Pfizer Pharmaceuticals, stock and meeting expense reimbursement from Altus labs, and personal fees from ParaPRO outside the submitted work. No other disclosures were reported. Publisher Copyright: © 2016 Optical Society of America.

PY - 2016/3/9

Y1 - 2016/3/9

N2 - We designed and fabricated a novel terahertz (THz) otoscope to help physicians to diagnose otitis media (OM) with both THz diagnostics and conventional optical diagnostics. We verified the potential of this tool for diagnosing OM using mouse skin tissue and a human tympanic membrane samples prior to clinical application.

AB - We designed and fabricated a novel terahertz (THz) otoscope to help physicians to diagnose otitis media (OM) with both THz diagnostics and conventional optical diagnostics. We verified the potential of this tool for diagnosing OM using mouse skin tissue and a human tympanic membrane samples prior to clinical application.

UR - http://www.scopus.com/inward/record.url?scp=84962833554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962833554&partnerID=8YFLogxK

U2 - 10.1364/BOE.7.001201

DO - 10.1364/BOE.7.001201

M3 - Article

AN - SCOPUS:84962833554

SN - 2156-7085

VL - 7

SP - 1201

EP - 1209

JO - Biomedical Optics Express

JF - Biomedical Optics Express

IS - 4

ER -

Terahertz otoscope and potential for diagnosing otitis media

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this